View Discovery
Trials for Market Approval
Download PPTPre-Clinical (GLP)
Guangzhou Institute of Respiratory Medicine Company Limited, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Phase 1
GlaxoSmithKline, TB Drug Accelerator, Bill & Melinda Gates Foundation
TB Alliance, ERA4TB (European Regimen Accelerator for Tuberculosis), University of Auckland, Merck & Co., Inc.
BioVersys AG, GlaxoSmithKline
iM4TB - Innovative Medicines for Tuberculosis, Bill & Melinda Gates Foundation
TB Alliance, University of Auckland
Phase 2
Shanghai Jiatan Biotech Ltd., subsidiary of Guangzhou JOYO Pharma Ltd., Shanghai, China
Otsuka Pharmaceutical Development & Commercialization, Inc.
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF), European and Developing Countries Clinical Trials Partnership (EDCTP), Radboud University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
LegoChem Biosciences, Inc.
GlaxoSmithKline, European Union Horizon 2020, NIAID, NIH, DHHS
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
TB Alliance, Bill & Melinda Gates Medical Research Institute, Foundation for Neglected Disease Research
TB Alliance
CDC TBTC, NIAID, NIH, DHHS, Boston University
Phase 3
Janssen Research & Development, LLC
Otsuka Pharmaceutical Development & Commercialization, Inc.
Médecins Sans Frontières
Novartis